Bone Health Technologies announces that the United States Patent and Trademark Office (USPTO) has awarded its second patent for the OsteoBoost Vibration Belt, which is specifically designed to treat osteopenia and prevent osteoporosis.

This patent covers the OsteoBoost tracking and reporting features, as well as for a wearable apparatus for treating or preventing osteoporosis. This patent builds on a previously awarded patent for devices and methods to dynamically calibrate the precise therapeutic vibration of the OsteoBoost Vibration Belt, the San Francisco-based company notes in a media release.

“Osteopenia and osteoporosis are a major public health problem in need of innovation – I am proud of the work we are doing to bring safe and effective treatments to the tens of millions of patients at risk of fracture and are thrilled to see the novelty of this mechanism recognized.”

— Laura Yecies, CEO of Bone Health Technologies

The company recently announced the close of its $2.5 million funding round and the appointment of three board members. It recently appointed CEO Laura Yecies and was granted Breakthrough Device Designation by the FDA for OsteoBoost, the first vibration belt specifically designed for the treatment of osteopenia and prevention of osteoporosis.

At the 2021 One Harvard New Venture Competition, Bone Health Technologies was awarded both the One Harvard New Venture Competition Grand Prize Winner and Northern California Crowd Favorite titles and won the grand prize at the 2021 Dartmouth Entrepreneur Competition.

OsteoBoost is based on NASA research suggesting that medical stimulation of bones through vibration would improve bone health in astronauts. Studies have shown that one 30-minute treatment with OsteoBoost reduced bone loss activity in all study participants.

[Source: Bone Health Technologies]

Related Content:
Bone Health Technologies Closes $2.5M Funding Round and Appoints New Board Members
OsteoBoost Vibration Belt Obtains FDA ‘Breakthrough’ Designation